Literature DB >> 20576953

MicroRNAs induced during ischemic preconditioning.

Soon-Tae Lee1, Kon Chu, Keun-Hwa Jung, Hye-Jin Yoon, Daejong Jeon, Kyoung-Mook Kang, Ki-Ho Park, Eun-Kee Bae, Manho Kim, Sang Kun Lee, Jae-Kyu Roh.   

Abstract

BACKGROUND AND
PURPOSE: MicroRNAs (miRNA) are single-stranded short RNA molecules that regulate gene expression by either degradation or translational repression of mRNA. Although miRNAs control a number of conditions and diseases, few neuroprotective miRNAs have been described. In this study, we investigated neuroprotective miRNAs induced early in ischemic preconditioning.
METHODS: Ischemic preconditioning or focal cerebral ischemia was induced in mice by transient occlusion of the middle cerebral artery for 15 or 120 minutes. We prepared RNA samples from the ischemic cortex at 3 or 24 hours after the onset of ischemia. Selective miRNAs then were synthesized and transfected into Neuro-2a cells before oxygen-glucose deprivation.
RESULTS: We detected a total of 360 miRNAs. Two miRNA families, miR-200 and miR-182, were selectively upregulated at 3 hours after ischemic preconditioning. Transfections of some of these were neuroprotective in in vitro ischemia. Among them, miR-200b, miR-200c, and miR-429 targeted prolyl hydroxylase 2 and had the best neuroprotective effect.
CONCLUSIONS: Two miRNA families, miR-200 and miR-182, were upregulated early after ischemic preconditioning and the miR-200 family was neuroprotective mainly by downregulating prolyl hydroxylase 2 levels. These miRNAs may be useful in future research and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576953     DOI: 10.1161/STROKEAHA.110.579649

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  109 in total

Review 1.  MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.

Authors:  Jia-Su Li; Zhong-Xiang Yao
Journal:  Mol Neurobiol       Date:  2012-01-05       Impact factor: 5.590

Review 2.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

3.  Differential expression of microRNAs during allograft rejection.

Authors:  L Wei; M Wang; X Qu; A Mah; X Xiong; A G C Harris; L K Phillips; O M Martinez; S M Krams
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

4.  Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.

Authors:  Ross C McKiernan; Eva M Jimenez-Mateos; Takanori Sano; Isabella Bray; Raymond L Stallings; Roger P Simon; David C Henshall
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

Review 5.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

6.  Regulation of gene expression in ischemic preconditioning in the brain.

Authors:  Tuo Yang; Qianqian Li; Feng Zhang
Journal:  Cond Med       Date:  2017-12-15

Review 7.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

8.  Postnatal choline supplementation selectively attenuates hippocampal microRNA alterations associated with developmental alcohol exposure.

Authors:  Sridevi Balaraman; Nirelia M Idrus; Rajesh C Miranda; Jennifer D Thomas
Journal:  Alcohol       Date:  2017-01-03       Impact factor: 2.405

Review 9.  Reprogramming the response to stroke by preconditioning.

Authors:  Susan L Stevens; Keri B Vartanian; Mary P Stenzel-Poore
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

10.  Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation.

Authors:  Benjamin Buller; Michael Chopp; Yuji Ueno; Li Zhang; Rui Lan Zhang; Daniel Morris; Yi Zhang; Zheng Gang Zhang
Journal:  Glia       Date:  2012-08-20       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.